Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.60
+0.08 (0.76%)
At close: Oct 9, 2026, 4:00 PM EDT
10.61
+0.01 (0.09%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Kura Oncology Employees
Kura Oncology had 260 employees as of December 31, 2025. The number of employees increased by 68 or 35.42% compared to the previous year. That makes Kura Oncology the 24,913th largest employer in the world and 3,196th in the United States.
Employees
260
Change (1Y)
68
Growth (1Y)
35.42%
Revenue / Employee
$297,019
Profits / Employee
-$1,141,442
Market Cap
942.98M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 704 |
| Rigel Pharmaceuticals | 174 |
| Monte Rosa Therapeutics | 173 |
| MoonLake Immunotherapeutics | 130 |
| Adlai Nortye Group | 109 |
| Cullinan Therapeutics | 109 |
| Alto Neuroscience | 68 |
| Seaport Therapeutics | 58 |
KURA News
- 2 days ago - Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian's Launch and KO-7246 Preclinical Data in Diabetes - GlobeNewsWire
- 7 days ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - Kura Oncology initiated with an Overweight at JPMorgan - TheFly
- 10 days ago - Kura Oncology’s KO-7246 shows positive results as menin inhibitor in diabetes - TheFly
- 10 days ago - Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes - GlobeNewsWire
- 23 days ago - Kura Oncology Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 weeks ago - Kura Oncology Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 4 weeks ago - Kura Oncology launches Caspian Therapeutics - TheFly